Heidelberg Pharma AG

Director's Dealing • Apr 10, 2015

News Details

Directors’ Dealings | 10 April 2015 10:20

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Krebs First name: Andreas R. Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: Bearer shares of common stock ISIN/WKN of the financial instrument: DE000A11QVV0 Type of transaction: Purchase via subscription rights Date: 07.04.2015 Price: 2.80 Currency: EUR No. of items: 2380 Total amount traded: 6664.00 Place: OTC / Außerbörslich Explanation for publication: Subscription of new shares from a rights issue, registered in the Commercial Register on 10 April 2015 Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Germany ISIN: DE000A11QVV0 WKN: A11QVV End of Directors’ Dealings Notification (c) DGAP 10.04.2015 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 21139